Rilpivirine Action Pathway,Drug Action,Rilpivirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) which is used for the treatment of HIV-1 infections in treatment-naive patients. It binds to reverse transcriptase which results in a block in RNA and DNA- dependent DNA polymerase activities. One such activity is HIV-1 replication. Intracellular phosphorylation is not necessary for its antiviral activity.
rilpivirine action pathway,drug action,rilpivirine is non-nucleoside reverse transcriptase inhibitor (nnrti) which is used for the treatment of hiv-1 infections in treatment-naive patients. it binds to reverse transcriptase which results in a block in rna and dna- dependent dna polymerase activities. one such activity is hiv-1 replication. intracellular phosphorylation is not necessary for its antiviral activity.
Rilpivirine Action Pathway,Drug Action,Rilpivirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) which is used for the treatment of HIV-1 infections in treatment-naive patients. It binds to reverse transcriptase which results in a block in RNA and DNA- dependent DNA polymerase activities. One such activity is HIV-1 replication. Intracellular phosphorylation is not necessary for its antiviral activity.
rilpivirine action pathway,drug action,rilpivirine is non-nucleoside reverse transcriptase inhibitor (nnrti) which is used for the treatment of hiv-1 infections in treatment-naive patients. it binds to reverse transcriptase which results in a block in rna and dna- dependent dna polymerase activities. one such activity is hiv-1 replication. intracellular phosphorylation is not necessary for its antiviral activity.